GleamWall
中文EN

PFE PFIZER INC

Pharmaceutical Preparations · NYSE · SEC CIK 78003 · Fiscal year ends 12/31

Financial factors as of 2026-09-27 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.3%
TTM net income YoY-59.0%
TTM EPS YoY-59.3%
Revenue 3-yr CAGR-2.8%
Net income 3-yr CAGR-27.3%

Margins

Gross margin73.4%
Operating margin—
Net margin6.3%
FCF margin18.5%
EBITDA margin—

Returns

ROE4.4%
ROA2.0%
ROIC (approx.)—
Asset turnover0.31x

Leverage & solvency

Liabilities / assets56.3%
Debt / equity0.70x
Current ratio1.42x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.51x
Accruals ratio-4.9%
Payout ratio—
Capex / revenue3.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$62.58B$63.63B
Cost of revenue$16.07B$17.85B
Gross profit$46.51B$45.78B
R&D expense$10.44B$10.82B
SG&A expense$13.79B$14.73B
Interest expense$2.67B$3.09B
Pretax income$7.52B$8.02B
Income tax-$266.00M-$28.00M
Net income$7.77B$8.03B
EPS (basic)1.371.42
EPS (diluted)1.361.41
Dividends declared per share1.721.69
Weighted avg. shares (diluted)5.71B5.70B
Balance sheet
Cash & equivalents$1.14B$1.11B
Short-term investments$9.18B$10.88B
Receivables$11.87B$11.46B
Inventory$10.65B$10.85B
Current assets$42.90B$50.36B
PP&E, net$19.32B$18.39B
Goodwill$71.26B$68.53B
Intangibles$53.73B$55.41B
Total assets$208.16B$213.40B
Current liabilities$36.98B$42.99B
Short-term debt$3.15B$6.95B
Long-term debt$61.64B$57.41B
Total debt$64.80B$64.35B
Total liabilities$121.39B$124.90B
Shareholders' equity$86.48B$88.20B
Net debt$63.65B$63.24B
Cash flow statement
Operating cash flow$11.70B$12.74B
Capital expenditure$2.63B$2.91B
Free cash flow$9.07B$9.84B
Investing cash flow-$1.35B$2.65B
Financing cash flow-$10.30B-$17.14B
Depreciation & amortization$6.59B$7.01B
Stock-based compensation$799.00M$877.00M
Share buybacks—$0

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.